BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
QuintilesIMS
Accenture
Boehringer Ingelheim
Chubb
Farmers Insurance
Novartis
Cantor Fitzgerald
Baxter
Harvard Business School

Generated: January 21, 2018

DrugPatentWatch Database Preview

Cefamandole nafate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefamandole nafate and what is the scope of cefamandole nafate freedom to operate?

Cefamandole nafate
is the generic ingredient in one branded drug marketed by Lilly and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for cefamandole nafate.
Summary for cefamandole nafate
Medical Subject Heading (MeSH) Categories for cefamandole nafate

US Patents and Regulatory Information for cefamandole nafate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 062560-001 Sep 10, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 050504-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 050504-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 050504-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 062560-002 Sep 10, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly MANDOL cefamandole nafate INJECTABLE;INJECTION 050504-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Medtronic
Boehringer Ingelheim
US Department of Justice
Baxter
Chinese Patent Office
Johnson and Johnson
Deloitte
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot